Expert in treating complex oncological cases with 76 years of experience of research published in leading medical journals.
Internationally recognized oncologist with over 22 years of experience of experience leading clinical divisions and research in targeted cancer therapies. He practices personalized medicine at Wiener Privatklinik.
Chief Physician at a certified cancer center, Phd Viola Fox specializes in innovative treatments for testicular cancer.
Associate Professor Tahsin Ozatli specializes in breast, lung, and gastrointestinal cancers at Istinye Liv University Hospital.
Professor Keil specializes in interventional radiology, using advanced imaging to guide precise treatments. Currently heads the Diagnostic and Interventional Radiology Clinic at Academic Hospital Solingen.
Associate Professor Dr. Yusuf Acikgoz brings international oncology expertise from Ohio State University to Lokman Hekim University Ankara Hospital.
Professor Cemil Bilir brings over 21 years of experience of specialized experience in medical oncology, with training at top institutions like Cleveland Clinic and Northeastern University.
Associate Professor Nail Paksoy specializes in testicular cancer treatment, with a medical oncology fellowship from Istanbul University and ESMO Board Certification.
Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.
Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).
Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).
Dr. Ozden brings over 27 years of experience of experience in internal medicine and medical oncology, specializing in testicular cancer at VM Medical Park Pendik Hospital.
Dr. Michael Van Kampen is a dedicated radiotherapy specialist at Nordwest Clinic, focusing on precision cancer treatments.
Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.
He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.
Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.
Specializing in medical oncology, Dr. Alemdar brings focused expertise in testicular cancer at Medical Park Antalya Hospital Complex.
Head of the Urology Department at Rambam Medical Center, Dr. Amiel specializes in urologic oncology.
Dr. Joseba Rebollo Liceaga brings over 36 years of experience of oncology experience, specializing in testicular cancer at Quironsalud Torrevieja.
Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).
He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.
Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.
Professor Eduard Becht leads an interdisciplinary uro-oncology association and has over four decades of experience.
49 years of experience specializing in virotherapy – Dr. Jaunalksne leads the Clinical Immunology Center at Pauls Stradins Clinical University Hospital.